Russell Investments Group
BBNX icon

Russell Investments Group’s Beta Bionics BBNX Stock Holding History

Russell Investments Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
11,752
-11,929
-50% -$142K ﹤0.01% 3211
2026
Q1 		$237K Sell
23,681
-182,156
-88% -$2.69M ﹤0.01% 2796
2025
Q4 		$6.27M Buy
205,837
+111,610
+118% +$2.98M 0.01% 1173
2025
Q3 		$1.87M Buy
94,227
+93,412
+11,462% +$1.64M ﹤0.01% 1897
2025
Q2 		$11.9K Buy
+815
New +$11.5K ﹤0.01% 3298

Other funds holding BBNX

Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Russell Investments Group's BBNX Position: Q2 2026 in Review

Russell Investments Group reduced its Beta Bionics (BBNX) stake by 50% in Q2 2026, selling an estimated $142K and leaving 11,752 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

Russell Investments Group first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.27M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Russell Investments Group held 11,752 shares of Beta Bionics worth $184K as of Q2 2026.
  • Russell Investments Group sold 11,929 Beta Bionics shares in Q2 2026, an estimated $142K.
  • Beta Bionics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3211 holding.
  • Russell Investments Group first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • Russell Investments Group's Beta Bionics position peaked at $6.27M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.